首页> 外文期刊>Pulmonary pharmacology & therapeutics >Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways
【24h】

Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways

机译:双磷酸二酯酶(PDE)3/4抑制剂RPL554和格隆铵在人分离的支气管和小气道上相互作用的药理学表征

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The dual PDE3/4 inhibitor RPL 554 causes bronchodilation in patients with asthma or COPD and synergistically interacts with muscarinic receptor antagonists in relaxing human isolated bronchi in acute experimental settings. In the present study we investigated the long-lasting interaction between RPL554 and glycopyrronium by testing these drugs for their ability to relax both medium and small human isolated bronchi.
机译:背景:双重PDE3 / 4抑制剂RPL 554在哮喘或COPD患者中导致支气管扩张,并在急性实验环境中与人毒蕈碱受体拮抗剂协同作用,使人分离的支气管舒张。在本研究中,我们通过测试RPL554和格隆溴铵在中小人体分离支气管中的松弛能力来研究它们之间的持久相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号